Feline coronavirus quantitative reverse-transcriptase polymerase chain reaction on effusion samples in cats with and without feline infectious peritonitis by Longstaff, Louise et al.
                          Longstaff, L., Porter, E. L., Crossley, V. J., Hayhow, S., Helps, C. R., &
Tasker, S. (2017). Feline coronavirus quantitative reverse-transcriptase
polymerase chain reaction on effusion samples in cats with and without
feline infectious peritonitis. Journal of Feline Medicine and Surgery, 19(2),
240-245. DOI: 10.1177/1098612X15606957
Peer reviewed version
Link to published version (if available):
10.1177/1098612X15606957
Link to publication record in Explore Bristol Research
PDF-document
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
Feline coronavirus quantitative reverse-transcriptase polymerase chain reaction on 1 
effusion samples in cats with and without feline infectious peritonitis 2 
 3 
L. Longstaff*, E. Porter*, V. J. Crossley, S. E. Hayhow, C. R. Helps, & S. Tasker§ 4 
 5 
Longstaff, L. The Feline Centre, Langford Veterinary Services and School of Veterinary 6 
Sciences, University of Bristol, Langford, Bristol, UK. 7 
Porter, E. School of Veterinary Sciences, University of Bristol, Langford, Bristol, UK. 8 
Crossley, V. The Feline Centre, Langford Veterinary Services and School of Veterinary 9 
Sciences, University of Bristol, Langford, Bristol, UK. 10 
Hayhow, S. School of Veterinary Sciences, University of Bristol, Langford, Bristol, UK. 11 
Helps, C. R. Molecular Diagnostic Unit, Langford Veterinary Services, Langford, Bristol, BS40 12 
5DU.  13 
* These authors contributed equally to this manuscript 14 
 15 
§Corresponding author 16 
Séverine Tasker BSc BVSc PhD DSAM DipECVIM-CA FHEA MRCVS 17 
E-mail: s.tasker@bristol.ac.uk 18 
Address: The Feline Centre and Molecular Diagnostic Unit, Langford Veterinary Services and 19 
School of Veterinary Sciences, University of Bristol, Langford, Bristol, UK. 20 
Telephone: + 44 (0) 117 928 9280 21 
 22 
Keywords: feline, diagnosis, coronavirus, mutation, effusion, feline infectious peritonitis 23 
Abbreviated short title: Feline coronavirus polymerase chain reaction in the diagnosis of wet 24 
feline infectious peritonitis  25 
Abstract 26 
Objectives: To determine whether feline coronavirus (FCoV) RNA in effusion samples can be 27 
used as a diagnostic marker of feline infectious peritonitis (FIP), and in FCoV RNA positive 28 
samples, to examine amino acid codons in the FCoV spike protein at positions 1058 and 1060 29 
where leucine and alanine, respectively, have been associated with systemic or virulent (FIP) 30 
FCoV infection.   31 
Methods: Total RNA was extracted from effusion samples from 20 cats with confirmed FIP and 32 
23 cats with other diseases. Feline coronavirus RNA was detected using a reverse transcriptase 33 
quantitative polymerase chain reaction assay (qRT-PCR) and positive samples underwent 34 
pyrosequencing of position 1058 and Sanger sequencing of position 1060 in the FCoV spike 35 
protein. 36 
Results: Seventeen (85%) of effusion samples from 20 cats with FIP were positive for FCoV 37 
RNA, whereas none of the 23 cats with other diseases were positive. Pyrosequencing of the 17 38 
FCoV positive samples showed that 11 (65%) of cats had leucine and 2 (12%) had methionine 39 
at position 1058. Of the two samples with methionine, one had alanine at position 1060. 40 
Conclusions and relevance: A positive FCoV qRT-PCR result on effusions appears specific 41 
for FIP and may be a useful diagnostic marker for FIP in cats with effusions. The majority of 42 
FCoVs contained amino acid changes previously associated with systemic spread or virulence 43 
(FIP) of the virus. 44 
  45 
Introduction 46 
Feline coronavirus (FCoV) infection is common in domestic cat populations worldwide1-3. Most 47 
infections are enteric and self-limiting. In a small number of cases, FCoV infection can lead to 48 
the development of feline infectious peritonitis (FIP), a significant cause of mortality in young 49 
cats.  50 
Definitive diagnosis of FIP relies on histopathological examination of affected tissues, ideally 51 
with detection of intracellular FCoV antigen by immunostaining1, 4, 5.  Obtaining tissue samples is 52 
invasive and problematic for ante mortem diagnosis.  In many FIP cases, abdominal, pleural 53 
and/or pericardial effusions develop2, which can usually be easily obtained for diagnostic 54 
testing.  Previous studies have reported the use of FCoV antigen staining in effusion samples in 55 
the diagnosis of FIP, with sensitivity and specificity of 57-100% and 71.5-100%, respectively6-9. 56 
Feline coronavirus RNA can be detected in samples using conventional or quantitative reverse 57 
transcriptase polymerase chain reaction assays (qRT-PCR).  Studies on tissues using qRT-58 
PCRs have found that cats with FIP have significantly higher FCoV loads in tissues than healthy 59 
or sick (non-FIP) FCoV infected cats5, 10, 11.  It is possible that the same is true for effusion 60 
samples. Previous studies performing FCoV conventional PCR on effusion samples from cats 61 
with FIP have shown promising results, but were limited either by lack of definitive diagnosis of 62 
cases12, or lack of control non-FIP cats13. 63 
The aim of this study was to perform FCoV qRT-PCR on effusions collected from cats with and 64 
without confirmed FIP to investigate whether the presence of FCoV RNA in effusions is helpful 65 
in diagnosing FIP. In addition, it has been reported that key amino acid substitutions 66 
(methionine to leucine at position 1058 and serine to alanine at position 1060) in the spike 67 
protein of FCoV may be associated with FCoV virulence14 or systemic infection11, therefore 68 
these substitutions were evaluated in FCoV positive effusions. 69 
Methods 70 
Fifty-nine samples of surplus abdominal, pleural and pericardial effusion, from 45 cats, 71 
submitted to the Diagnostic Laboratories of Langford Veterinary Services 2011-2012, were 72 
used. Samples had been collected into tubes containing either RNAlater (Sigma-Aldrich, UK), 73 
EDTA, or no preservative and stored at -20C upon receipt.  All cases classified as FIP were 74 
diagnosed by histopathology and subsequent immunohistological demonstration of FCoV 75 
antigen within macrophages in the lesions, whilst all cases classified as non-FIP were confirmed 76 
to have other diseases based on either histopathology and/or the presence of definitive 77 
diagnostic features of another disease (Table 1). Cases that could not be definitively classified 78 
were excluded from further analysis. 79 
Total RNA was purified from 100l of each effusion sample using a NucleoSpin RNA II kit 80 
(Macherey-Nagel, Fisher, UK), eluted in 50μl RNase-free water and stored at -80C. 81 
Quantitative RT-PCR was carried out as described previously11. A previous study has evaluated 82 
this qRT-PCR assay, and reported a reaction efficiency of 95.9%15. The assay has a sensitivity 83 
of between 1 and 10 copies of FCoV per assay (data not shown). Positive and negative controls 84 
(FCoV cDNA and RNase-free water, respectively) were used in all PCR runs. In cats where 85 
more than one type of effusion was collected and/or into different preservatives, only the sample 86 
yielding the lowest threshold cycle (CT) value was used in analysis. 87 
Pyrosequencing was performed on the FCoV qRT-PCR positive samples to identify methionine 88 
to leucine substitutions at position 1058 (M1058L) in the spike protein. A second substitution at 89 
position 1060 (serine to alanine; S1060A), was investigated using Sanger sequencing on 90 
samples showing methionine at position 1058. Methods were as described previously11. 91 
Positive and negative controls (control oligonucleotide or FCoV cDNA and RNase-free water, 92 
respectively) were used in all pyrosequencing and PCR sequencing runs. 93 
Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) of effusion qRT-94 
PCR for the diagnosis of FIP were calculated (MedCalc Software bvba, Beligum). 95 
Results 96 
Of the 45 cats, 20 (44%) were classified as FIP, 23 (51%) as non-FIP and two (5%) were 97 
unclassified and thus excluded (Table 1).  Of the 20 FIP cats, one effusion sample was obtained 98 
from 13 cats, two samples from six cats and three samples from one cat. Of the 23 non-FIP 99 
cats, one sample was obtained from 19 cats, two samples from three cats and three samples 100 
from one cat.  Samples varied by collection site and/or preservative (Table 1). All collected 101 
samples were analysed by qRT-PCR, but as only one sample from each cat was used for 102 
analysis, a total of 43 samples were used.   103 
Seventeen of 20 cats (85%) with FIP had FCoV positive effusions, with CT values of 24.06-104 
38.27 (median 31.05). None of the 23 non-FIP cats had FCoV positive effusions (Table 1). All 105 
negative and positive controls gave appropriate results.  The effusion FCoV qRT-PCR assay 106 
had a sensitivity of 85%, a specificity of 100%, a PPV of 100% and a NPV of 88.5% for the 107 
diagnosis of FIP (Table 2). The 95% confidence intervals are also shown in Table 2.   108 
Pyrosequencing showed that of the 17 FCoV positive effusion FIP cats, 11 (65%) had leucine, 109 
and two (12%) had methionine, at position 1058.  Reliable sequence data could not be obtained 110 
for four (23%) cats (Table 1). Of the two cats with methionine at position 1058, only one had 111 
alanine at position 1060. Controls for all assays were appropriately positive and negative. 112 
Discussion 113 
We have investigated the presence of FCoV RNA in abdominal, pleural or pericardial effusion 114 
samples from cats with and without FIP.  Our results show that in this group of samples, a 115 
positive FCoV qRT-PCR result was highly specific, with no non-FIP cats generating positive 116 
results. However, sensitivity was only 85%.  These figures are similar to those recently reported 117 
for cerebrospinal fluid FCoV qRT-PCR in cats with neurological and/or ocular FIP and non-FIP 118 
cats, where a specificity of 100% and sensitivity of 85.7% for FIP were reported16. 119 
The CT values of positive qRT-PCR results were 24.1-38.3, representing a ~16,000 fold 120 
variation in the level of FCoV RNA present.  Indeed, the CT values of 7/17 FCoV positive cats 121 
were >34.0, representing relatively low levels of FCoV RNA.  It is possible that the samples from 122 
the three FIP cases that generated negative FCoV qRT-PCR results had FCoV present, but at 123 
levels below the limit of detection of the PCR.  Repeated analysis of samples containing levels 124 
of RNA close to the detection limit of the PCR assay can generate either positive or negative 125 
results, dependent on whether adequate template is present in the aliquot used in the PCR15. 126 
Additionally, levels of FCoV in cats with FIP vary in different tissues, likely mirroring the 127 
pathological changes present5, and in some cases are too low to be detected by PCR5, 11, 17, 128 
lending support to the premise that negative results in FIP cases may be due to the presence of 129 
very low levels of FCoV in these effusions. A recent study by Pedersen et al5 reported that the 130 
cellular portion of ascitic FIP samples had 10-1000 times more viral RNA than the supernatant, 131 
with most FCoV within macrophages of the effusion. Thus, in the future, it would be interesting 132 
to perform FCoV qRT-PCR on effusion samples subjected to centrifugation, in an attempt to 133 
concentrate cellular material and any FCoV present, and potentially improve sensitivity.    134 
The finding that FCoV was not detectable in any of the non-FIP cats contributed to the high 135 
specificity seen for the PCR. Feline coronavirus infection can be systemic in non-FIP cats10, 11, 136 
18-20, therefore some FCoV positive effusion samples might have been expected in our non-FIP 137 
group. Lack of such cases may be due to the nature of those included in the study.  A large 138 
number of non-FIP cats had neoplasia and these cats tended to be older than the FIP cats, so 139 
may have been less likely to be infected with FCoV.  The true FCoV status of the non-FIP cases 140 
could not be determined for this study. Furthermore, FCoV levels in systemic FCoV-infected 141 
non-FIP cats are often low10, 11, and may have been below the sensitivity of the FCoV qRT-PCR 142 
assay. A possible limitation of this study is the general recruitment of effusion samples 143 
submitted to a diagnostic laboratory, rather than targeting samples in which FIP was suspected 144 
as a major differential diagnosis.  Non-targeted recruitment was performed to maximise case 145 
numbers, however, some cats in the non-FIP group presented with inflammatory disease, 146 
where FIP would have been considered a differential.  147 
Our study found that the majority of effusions from FIP cats that generated FCoV sequence 148 
data for the amino acid positions 1058 and 1060 contained substitutions concordant with the 149 
systemic form of FCoV11 and virulence14. Only one FIP cat generated sequence data previously 150 
associated with non-systemic (enteric) FCoV11 or in healthy 14 cats, with methionine and serine 151 
at positions 1058 and 1060 respectively. The FCoV in this cat may have had alternative 152 
substitutions elsewhere in the genome responsible for systemic FCoV virulence.  153 
In conclusion, this study suggests that a positive FCoV qRT-PCR result on effusions is highly 154 
indicative of FIP, and may therefore be a useful diagnostic tool in the investigation of suspected 155 
cases that present with an effusion.  However, further evaluation of this test’s sensitivity and 156 
specificity is required, using a larger sample size that includes FCoV-infected cats that do not 157 
have FIP.  158 
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Table 1. Characteristics of effusion samples from the 45 cats recruited in the study.  232 
Cat 
numb
er 
FIP 
classificati
on 
Age 
(year
s) 
Sex Breed Diagnosis 
Source 
of 
effusio
n 
sample 
Preservat
ive 
CT value 
for FCoV 
qRT-PCR 
Pyrosequen
cing result 
for position 
1058 
1 FIP - - - FIP 
Abdomi
nal 
None 24.06 Leucine 
2 FIP 0.6 M DSH FIP Pleural EDTA 24.38 Leucine 
3 FIP 0.6 MN Ragdoll FIP 
Abdomi
nal 
None 26.64 Leucine 
4 FIP 0.4 - DSH FIP Pleural RNAlater 27.05 Leucine 
5 FIP - - DSH FIP Pleural None 27.98 Methionine1 
6 FIP 0.4 ME 
Scottish 
Fold 
FIP Pleural None 29.47 Leucine 
7 FIP - M DSH FIP 
Abdomi
nal 
None 30.10 Leucine 
8 FIP 3 FN - FIP 
Abdomi
nal 
None 30.66 Leucine 
9 FIP 0.7 FE Ragdoll FIP 
Abdomi
nal 
None 31.05 Methionine2 
10 FIP 0.3 ME 
Bengal 
cross 
FIP 
Abdomi
nal 
EDTA 33.94 
No clear 
sequence 
11 FIP 0.4 M BSH FIP Pleural None 35.02 
No clear 
sequence 
12 FIP 3 MN DSH FIP 
Pericar
dial 
EDTA 35.72 Leucine 
13 FIP 1 F BSH FIP 
Abdomi
nal 
EDTA 36.17 Leucine 
14 FIP 0.7 - Korat FIP 
Abdomi
nal 
RNAlater 36.96 Leucine 
15 FIP 0.4 FE Savannah FIP 
Abdomi
nal 
None 37.01 
No clear 
sequence 
16 FIP 0.3 M Bengal FIP 
Abdomi
nal 
EDTA 37.81 Leucine 
17 FIP 0.4 FE DSH FIP 
Abdomi
nal 
RNAlater 38.27 
No clear 
sequence 
18 FIP 7 FN DSH FIP 
Abdomi
nal 
None No CT ND 
19 FIP 0.9 MN Bengal FIP 
Abdomi
nal 
None No CT ND 
20 FIP 7 FN Birman FIP 
Abdomi
nal 
None No CT ND 
21 Non-FIP 13 FN DSH 
Thymoma with 
associated 
chylothorax 
Pleural None No CT ND 
22 Non-FIP 9 MN DSH 
Lymphohistiocytic 
thoracic neoplasm 
Pleural EDTA No CT ND 
23 Non-FIP 13 MN DSH 
Hyperthyroidism 
and hypertrophic 
cardiomyopathy 
associated 
congestive cardiac 
failure 
Pleural EDTA No CT ND 
24 Non-FIP 18 FN DSH 
Severe protein 
losing enteropathy 
Abdomi
nal 
None No CT ND 
25 Non-FIP 0.3 M Exotic 
Idiopathic 
chylothorax 
Pleural EDTA No CT ND 
26 Non-FIP 8 FN DSH 
Intestinal 
carcinomatosis 
Abdomi
nal 
EDTA No CT ND 
27 Non-FIP 10 FN DSH 
Cholangiocarcinoma 
with carcinomatosis 
Abdomi
nal 
None No CT ND 
28 Non-FIP 1 FN 
Maine 
Coon 
Fibrous (non-
inflammatory) 
lesions present 
throughout 
abdominal cavity – 
aetiology not known 
Pleural None No CT ND 
29 Non-FIP 10 FN Somali 
Feline triaditis 
(pancreatitis, 
Abdomi
nal 
None No CT ND 
cholangitis and 
inflammatory bowel 
disease) 
30 Non-FIP 15 MN DSH 
Large cell 
lymphoma of small 
intestine and liver 
Abdomi
nal 
None No CT ND 
31 Non-FIP 8 FN DSH Thymoma Pleural EDTA No CT ND 
32 Non-FIP 11 FN DSH 
Possible 
mesothelioma, with 
mild neutrophilic 
inflammation 
Pleural EDTA No CT ND 
33 Non-FIP 4  FN Persian Intestinal lymphoma 
Abdomi
nal 
EDTA No CT ND 
34 Non-FIP 10 FN DLH 
Abdominal 
carcinoma 
Abdomi
nal 
EDTA No CT ND 
35 Non-FIP 1 FE 
Russian 
Blue 
Haemorrhagic 
effusion 
Abdomi
nal 
None No CT ND 
36 Non-FIP 8 FN DSH Hepatic carcinoma 
Abdomi
nal 
None No CT ND 
37 Non-FIP 8 MN DSH Chemodectoma Pleural None No CT ND 
38 Non-FIP 2 MN 
Tonkines
e 
Abdominal 
carcinoma 
Abdomi
nal 
EDTA No CT ND 
39 Non-FIP 13 MN Birman 
Restrictive 
cardiomyopathy 
Pleural EDTA No CT ND 
40 Non-FIP 3 F BSH 
Neutrophilic 
cholangitis 
Abdomi
nal 
RNAlater No CT ND 
41 Non-FIP 7 MN 
Devon 
Rex 
Lymphoplasmacytic 
inflammation of the 
liver and kidney 
Abdomi
nal 
None No CT ND 
42 Non-FIP 8 MN DLH Uroabdomen Pleural EDTA No CT ND 
43 Non-FIP 11 MN 
Maine 
Coon 
Diaphragmatic 
rupture 
Pleural None No CT ND 
44 
Unclassifie
d 
1 FN 
Maine 
Coon 
Pyothorax but could 
not rule out FIP as 
an underlying cause 
Abdomi
nal 
EDTA No CT ND 
45 
Unclassifie
d 
12 MN 
Russian 
Blue 
Unable to determine 
definitive diagnosis 
Abdomi
nal 
EDTA No CT ND 
 233 
- = Unknown, CT  = Threshold cycle value, qRT-PCR = reverse transcriptase quantitative polymerase chain reaction, FCoV = 234 
feline coronavirus 235 
DSH = Domestic Shorthair, BSH = British Shorthair, DLH = Domestic Longhair, M = male, F = female, N = neutered, E = 236 
entire 237 
ND = Samples negative for FCoV RNA by qRT-PCR which were therefore not submitted for pyrosequencing   238 
1 Sequencing result for position 1060 = Alanine 239 
2 Sequencing result for position 1060 = Serine. 240 
 241 
 242 
Table 2. Sensitivity, specificity, and positive and negative predictive values of effusion 243 
reverse transcriptase quantitative polymerase chain reaction for the diagnosis of FIP 244 
 245 
 Value  95% Confidence 
intervals 
Sensitivity 85.0% 65.1 - 96.8% 
Specificity 100.0% 85.2 – 100.0% 
Positive predictive value 100.0% 80.5 – 100.0% 
Negative predictive value 88.5% 69.9 - 97.6% 
Prevalence of FIP 46.5% 31.5 – 62.2% 
 246 
 247 
 248 
 249 
 250 
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 252 
 253 
